CANDRIAM S.C.A. – Keros Therapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$13.61M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+36.16%
quarter
Keros Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 3.61M | $37.62 | 361.77K | |
| Q2 2022 | share | Decrease | -14.00% | -58.89K shares | -12.88M | $27.63 | 361.77K |
| Q1 2022 | share | Increase | +74.59% | 179.72K shares | 8.77M | $54.38 | 420.67K |
| Q4 2021 | share | 0.00% | 0 shares | 4.56M | $56.3 | 240.94K | |
| Q3 2021 | share | Increase | +137.60% | 139.53K shares | 5.22M | $39.56 | 240.94K |
| Q2 2021 | share | Increase | 0.00% | 101.40K shares | 4.30M | $42.47 | 101.40K |